about
Minocycline as A Substitute for Doxycycline in Targeted Scenarios: A Systematic ReviewFirst Pharmacological Therapy for Hypoactive Sexual Desire Disorder in Premenopausal Women: Flibanserin.Physician-pharmacist collaboration versus usual care for treatment-resistant hypertension.New pharmacological therapies for vasomotor symptom management: focus on bazedoxifene/conjugated estrogens and paroxetine mesylate.Combining a GLP-1 receptor agonist and basal insulin: study evidence and practical considerations.Management Strategies for Clopidogrel Hypersensitivity.Quality of Life in Treatment-Resistant Hypertension.The changing cost to prevent diabetes: A retrospective analysis of the Diabetes Prevention Program.EPA-Registered Repellents for Mosquitoes Transmitting Emerging Viral Disease.Patient satisfaction with extended-interval warfarin monitoring.Health-related quality of life in persons with apparent treatment-resistant hypertension on at least four antihypertensives.Feasibility of Extended-interval Follow-up for Patients Receiving Warfarin.Pleiotropic effects of metformin to rescue statin-induced muscle injury and insulin resistance: A proposed mechanism and potential clinical implications.Metformin's Impact on Statin-Associated Muscle Symptoms: An analysis of ACCORD study data and research materials from the NHLBI Biologic Specimen and Data Repository Information Coordinating Center.Evaluation of SAMe-TT2R2 Score on Predicting Success With Extended-Interval Warfarin MonitoringReview of Prediabetes and Hypertensive Disorders of Pregnancy
P50
Q26771470-79C9FB87-E5C9-4ACF-9895-09909E07B5C4Q33166596-58169E1B-5D37-4A08-B51C-DF5AD61BE9E2Q36792041-59DF67BB-1491-403A-8CBF-673AD8F99CBDQ38230047-F5A2DC52-7C22-4760-9AB9-AE1B84D3E560Q38270132-A8C6014F-7BF3-43CE-899B-2EAA02DEFE84Q38521560-CF1A8005-C7CF-46EE-8C92-974692508131Q38538689-EB365A9F-CF13-4AF8-8608-CB0891E950BAQ38642606-76D078C0-2BA6-4A35-BCD6-E5A5CC8914CFQ38990309-DF916605-2D42-4992-B663-D1B9C7ACE3C9Q39717056-394EEDA7-00C9-474A-9A61-A458426480F1Q40826247-1F67CD09-8D4E-4EF5-A2D3-34923B9B3270Q41197426-DF6CCA8D-4CE1-493D-982F-64CF8B7997EEQ47977202-F17C5AFF-724D-411E-9F3B-F29F46F1134FQ51734951-2593BD8C-334F-442D-939E-20F38FCF5A48Q88953191-D20A1943-29EB-45CD-95E5-AB28B76C97DAQ91213102-44189394-D3B3-4392-A122-33FA4647B599
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nicholas W Carris
@ast
Nicholas W Carris
@en
Nicholas W Carris
@es
Nicholas W Carris
@nl
Nicholas W Carris
@sl
type
label
Nicholas W Carris
@ast
Nicholas W Carris
@en
Nicholas W Carris
@es
Nicholas W Carris
@nl
Nicholas W Carris
@sl
prefLabel
Nicholas W Carris
@ast
Nicholas W Carris
@en
Nicholas W Carris
@es
Nicholas W Carris
@nl
Nicholas W Carris
@sl
P1053
D-5154-2017
P106
P21
P31
P3829
P496
0000-0001-8904-5034